Latest filing published 27 Mar 2020 for TCR2 THERAPEUTICS INC., €303k.
Filing timeline
BuySaleInsider track record
Neil W. Gibson: trading record in brief
Filings by Neil W. Gibson span 2 companies, the busiest being Regulus Therapeutics Inc. and TCR2 Therapeutics Inc. We count 44 filings; the first trade dates from 4 February 2013 and the latest from 20 March 2020.
On the market, this insider has only sold: 24 sales, €2.1M in total. The rest of the record consists of 16 option exercises. In 2020 alone, the filings show no purchases and 6 sales.
The latest filing, published on 27 March 2020, reports a transaction in TCR2 Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Neil W. Gibson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 52,000 shares@ US$6.5264.4% of flowCommon StockSEC:0001209191-20-021385:3
- 17,723 shares@ US$6.6022.3% of flowCommon StockSEC:0001209191-20-021385:4
- 3,009 shares@ US$6.493.7% of flowCommon StockSEC:0001209191-20-021385:5
- 3,120 shares@ US$6.834.1% of flowCommon StockSEC:0001209191-20-021385:6
- 3,140 shares@ US$7.414.5% of flowCommon StockSEC:0001209191-20-021385:7
- 648 shares@ US$7.941.0% of flowCommon StockSEC:0001209191-20-021385:8
- 212,560 shares0Common StockSEC:0001209191-20-021385:0
- 196,177 shares0Common StockSEC:0001209191-20-021385:1
- 217,974 shares0Common StockSEC:0001209191-20-021385:2
- 706,351 sharesCommon StockSEC:0000899243-19-004393:0
- 71,345 shares@ US$17.98Common StockSEC:0001209191-15-008000:0
- 8,655 shares@ US$18.66Common StockSEC:0001209191-15-008000:1
- 2,500 shares@ US$1.74Common StockSEC:0001209191-14-071942:0
- 1,000 shares@ US$18.80Common StockSEC:0001209191-14-071942:1
- 1,500 shares@ US$19.63Common StockSEC:0001209191-14-071942:2
- 2,500 shares@ US$1.74Common StockSEC:0001209191-14-065581:0
- 1,100 shares@ US$18.68Common StockSEC:0001209191-14-065581:1
- 1,200 shares@ US$19.67Common StockSEC:0001209191-14-065581:2
- 200 shares@ US$20.41Common StockSEC:0001209191-14-065581:3
- 3,300 shares@ US$1.74Common StockSEC:0001209191-14-064729:0
- 3,300 shares@ US$14.44Common StockSEC:0001209191-14-064729:1
- 2,000 shares@ US$1.74Common StockSEC:0001209191-14-057928:0
- 2,000 shares@ US$8.01Common StockSEC:0001209191-14-057928:1
- 2,200 shares@ US$1.74Common StockSEC:0001209191-14-057928:2
- 2,200 shares@ US$8.01Common StockSEC:0001209191-14-057928:3
25 of 44 declarations
